You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RAPP Sale Disclosure
Ceesay Abraham · SEC Form 4 · Filed Sep 24, 2026
Sale
Calculated transaction value
$1.77K
Ceesay Abraham Chief Executive Officer
RAPP
Rapport Therapeutics
RAPP
Transaction date
Sep 23, 2026
Public filing date
Sep 24, 2026
Filing lag
Filed 1 day later
RAPP daily price context
Close on/before transaction
$34.13
Sep 23, 2026
First close after public filing
$33.91
Sep 25, 2026
30-day return after filing
-25.3%
Through Oct 26, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 43 shares @ $41.05
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-401017
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$86.57K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP | Sale | Sep 23, 2026 | $76.23K |
| Rapport Therapeutics, Inc. RAPP | Sale | Sep 23, 2026 | $8.57K |
| Rapport Therapeutics, Inc. RAPP Current | Sale | Sep 23, 2026 | $1.77K |